Robshaw & Julian Associates’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $553K | Hold |
10,000
| – | – | 0.4% | 40 |
|
|
2017
Q1 | $544K | Hold |
10,000
| – | – | 0.39% | 38 |
|
|
2016
Q4 | $584K | Hold |
10,000
| – | – | 0.43% | 38 |
|
|
2016
Q3 | $539K | Hold |
10,000
| – | – | 0.4% | 39 |
|
|
2016
Q2 | $736K | Hold |
10,000
| – | – | 0.56% | 37 |
|
|
2016
Q1 | $639K | Hold |
10,000
| – | – | 0.48% | 40 |
|
|
2015
Q4 | $688K | Hold |
10,000
| – | – | 0.53% | 37 |
|
|
2015
Q3 | $592K | Buy |
+10,000
| New | +$592K | 0.5% | 33 |
|
|
2014
Q3 | – | Sell |
-10,000
| Closed | -$485K | – | 36 |
|
|
2014
Q2 | $485K | Hold |
10,000
| – | – | 0.37% | 38 |
|
|
2014
Q1 | $520K | Hold |
10,000
| – | – | 0.4% | 38 |
|
|
2013
Q4 | $532K | Hold |
10,000
| – | – | 0.44% | 38 |
|
|
2013
Q3 | $463K | Buy |
+10,000
| New | +$463K | 0.39% | 39 |
|